Phase 1CompletedAge-related condition
Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women (YY_PK_2011)
Pharmacokinetics of a Single Oral Dose of Maxmarvil® in Healthy Postmenopausal Women Without a Previous History of Fractures
- Sponsor
- Yuyu Pharma, Inc. (Industry)
- Enrolment
- 18 enrolled
- Conditions
- Osteoporosis
- Interventions
- Maxmarvil®
- Ages
- adults, older adults
- Registry
- NCT01526278
Full record on ClinicalTrials.gov
From the registry
This study will evaluate clinical safety and pharmacokinetics of Maxmarvil® in healthy postmenopausal women
Primary outcomes
- analysis of Alendronate concentrate
History
Last registry update
Study completion
Primary completion
Registered
Started